BRIEF-Lilly says would not pursue tax inversions as "primary driver" of potential deals

July 24 Thu Jul 24, 2014 10:37am EDT

July 24 (Reuters) - Eli Lilly and Co : * CFO, in conference call with investors, says company would not pursue tax inversions as "primary driver" of any

potential merger * Says tax inversions would only be "secondary benefit" of any potenial mergers * Company says to delay phase III trial of osteoporosis drug that had been set to begin

in 2014

FILED UNDER: